84 related articles for article (PubMed ID: 21600112)
1. [The comparative study on high field MRI and pathology of Alzheimer's disease transgenic mice].
Li MH; Wang PJ; Chen SQ; Zhang W; Gao XL
Zhonghua Yi Xue Za Zhi; 2011 Apr; 91(13):876-9. PubMed ID: 21600112
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research.
Jack CR; Marjanska M; Wengenack TM; Reyes DA; Curran GL; Lin J; Preboske GM; Poduslo JF; Garwood M
Neuroscientist; 2007 Feb; 13(1):38-48. PubMed ID: 17229974
[TBL] [Abstract][Full Text] [Related]
3. Quantitative MRI reveals aging-associated T2 changes in mouse models of Alzheimer's disease.
Falangola MF; Dyakin VV; Lee SP; Bogart A; Babb JS; Duff K; Nixon R; Helpern JA
NMR Biomed; 2007 May; 20(3):343-51. PubMed ID: 17451178
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal assessment of Alzheimer's beta-amyloid plaque development in transgenic mice monitored by in vivo magnetic resonance microimaging.
Braakman N; Matysik J; van Duinen SG; Verbeek F; Schliebs R; de Groot HJ; Alia A
J Magn Reson Imaging; 2006 Sep; 24(3):530-6. PubMed ID: 16892201
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and amyloid plaque targeting ability of a novel peptide-based magnetic resonance contrast agent in wild-type and Alzheimer's disease transgenic mice.
Kandimalla KK; Wengenack TM; Curran GL; Gilles EJ; Poduslo JF
J Pharmacol Exp Ther; 2007 Aug; 322(2):541-9. PubMed ID: 17505020
[TBL] [Abstract][Full Text] [Related]
6. Neuropathology of mice carrying mutant APP(swe) and/or PS1(M146L) transgenes: alterations in the p75(NTR) cholinergic basal forebrain septohippocampal pathway.
Jaffar S; Counts SE; Ma SY; Dadko E; Gordon MN; Morgan D; Mufson EJ
Exp Neurol; 2001 Aug; 170(2):227-43. PubMed ID: 11476589
[TBL] [Abstract][Full Text] [Related]
7. Deposition of lactoferrin in fibrillar-type senile plaques in the brains of transgenic mouse models of Alzheimer's disease.
Wang L; Sato H; Zhao S; Tooyama I
Neurosci Lett; 2010 Sep; 481(3):164-7. PubMed ID: 20599473
[TBL] [Abstract][Full Text] [Related]
8. Detection of Aβ plaques by a novel specific MRI probe precursor CR-BSA-(Gd-DTPA)n in APP/PS1 transgenic mice.
Li S; He H; Cui W; Gu B; Li J; Qi Z; Zhou G; Liang CM; Feng XY
Anat Rec (Hoboken); 2010 Dec; 293(12):2136-43. PubMed ID: 21089051
[TBL] [Abstract][Full Text] [Related]
9. Cholinergic neuropathology in a mouse model of Alzheimer's disease.
German DC; Yazdani U; Speciale SG; Pasbakhsh P; Games D; Liang CL
J Comp Neurol; 2003 Aug; 462(4):371-81. PubMed ID: 12811807
[TBL] [Abstract][Full Text] [Related]
10. Hippocampal neuron loss exceeds amyloid plaque load in a transgenic mouse model of Alzheimer's disease.
Schmitz C; Rutten BP; Pielen A; Schäfer S; Wirths O; Tremp G; Czech C; Blanchard V; Multhaup G; Rezaie P; Korr H; Steinbusch HW; Pradier L; Bayer TA
Am J Pathol; 2004 Apr; 164(4):1495-502. PubMed ID: 15039236
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance spectroscopic analysis of Alzheimer's disease mouse brain that express mutant human APP shows altered neurochemical profile.
Dedeoglu A; Choi JK; Cormier K; Kowall NW; Jenkins BG
Brain Res; 2004 Jun; 1012(1-2):60-5. PubMed ID: 15158161
[TBL] [Abstract][Full Text] [Related]
12. Urine formaldehyde level is inversely correlated to mini mental state examination scores in senile dementia.
Tong Z; Zhang J; Luo W; Wang W; Li F; Li H; Luo H; Lu J; Zhou J; Wan Y; He R
Neurobiol Aging; 2011 Jan; 32(1):31-41. PubMed ID: 19879019
[TBL] [Abstract][Full Text] [Related]
13. Ultra-high field 7T MRI: a new tool for studying Alzheimer's disease.
Kerchner GA
J Alzheimers Dis; 2011; 26 Suppl 3():91-5. PubMed ID: 21971453
[TBL] [Abstract][Full Text] [Related]
14. Beneficial effects of quetiapine in a transgenic mouse model of Alzheimer's disease.
He J; Luo H; Yan B; Yu Y; Wang H; Wei Z; Zhang Y; Xu H; Tempier A; Li X; Li XM
Neurobiol Aging; 2009 Aug; 30(8):1205-16. PubMed ID: 18079026
[TBL] [Abstract][Full Text] [Related]
15. Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1.
Ohno M; Chang L; Tseng W; Oakley H; Citron M; Klein WL; Vassar R; Disterhoft JF
Eur J Neurosci; 2006 Jan; 23(1):251-60. PubMed ID: 16420434
[TBL] [Abstract][Full Text] [Related]
16. A novel transgenic rat model with a full Alzheimer's-like amyloid pathology displays pre-plaque intracellular amyloid-beta-associated cognitive impairment.
Leon WC; Canneva F; Partridge V; Allard S; Ferretti MT; DeWilde A; Vercauteren F; Atifeh R; Ducatenzeiler A; Klein W; Szyf M; Alhonen L; Cuello AC
J Alzheimers Dis; 2010; 20(1):113-26. PubMed ID: 20164597
[TBL] [Abstract][Full Text] [Related]
17. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
van Groen T; Kiliaan AJ; Kadish I
Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
[TBL] [Abstract][Full Text] [Related]
18. Bone-marrow-derived cells contribute to the recruitment of microglial cells in response to beta-amyloid deposition in APP/PS1 double transgenic Alzheimer mice.
Malm TM; Koistinaho M; Pärepalo M; Vatanen T; Ooka A; Karlsson S; Koistinaho J
Neurobiol Dis; 2005 Feb; 18(1):134-42. PubMed ID: 15649704
[TBL] [Abstract][Full Text] [Related]
19. Changes in cerebral blood volume and amyloid pathology in aged Alzheimer APP/PS1 mice on a docosahexaenoic acid (DHA) diet or cholesterol enriched Typical Western Diet (TWD).
Hooijmans CR; Rutters F; Dederen PJ; Gambarota G; Veltien A; van Groen T; Broersen LM; Lütjohann D; Heerschap A; Tanila H; Kiliaan AJ
Neurobiol Dis; 2007 Oct; 28(1):16-29. PubMed ID: 17720508
[TBL] [Abstract][Full Text] [Related]
20. Selective cholinergic denervation, independent from oxidative stress, in a mouse model of Alzheimer's disease.
Aucoin JS; Jiang P; Aznavour N; Tong XK; Buttini M; Descarries L; Hamel E
Neuroscience; 2005; 132(1):73-86. PubMed ID: 15780468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
